(Q55461244)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24469855%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

title

Conditional probability of survival and post-progression survival in patients with glioblastoma in the temozolomide treatment era (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24469855%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

0 references

1 reference

Normand J. Laperriere

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24469855%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Mairéad Mcnamara

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24469855%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

6

Arjun Sahgal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24469855%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

author name string

Zarnie Lwin

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24469855%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Haiyan Jiang

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24469855%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Caroline Chung

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24469855%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Barbara-Ann Millar

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24469855%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Warren P Mason

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24469855%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

publication date

29 January 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24469855%20AND%20SRC:MED&resulttype=core&format=json

Journal of Neuro-Oncology

6 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24469855%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

volume

117

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24469855%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24469855%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

page(s)

153-160

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24469855%20AND%20SRC:MED&resulttype=core&format=json

Brain and other central nervous system tumors: rates, trends, and epidemiology.

6 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1368-7

Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1368-7

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1368-7

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1368-7

Conditional probability of survival in patients with newly diagnosed glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1368-7

Conditional probability of long-term survival in glioblastoma: a population-based analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1368-7

Evidence for sequenced molecular evolution of IDH1 mutant glioblastoma from a distinct cell of origin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1368-7

Conditional survival of high-grade glioma in Los Angeles County during the year 1990-2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1368-7

Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1368-7

Prolonged temozolomide for treatment of glioblastoma: preliminary clinical results and prognostic value of p53 overexpression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1368-7

Screen for IDH1, IDH2, IDH3, D2HGDH and L2HGDH mutations in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1368-7

IDH mutations predict longer survival and response to temozolomide in secondary glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1368-7

Genetic pathways to glioblastoma: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1368-7

The conditional probability of survival of patients with primary malignant brain tumors: surveillance, epidemiology, and end results (SEER) data

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24469855